Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

Active, not recruitingOBSERVATIONAL
Enrollment

955

Participants

Timeline

Start Date

June 11, 2019

Primary Completion Date

March 31, 2027

Study Completion Date

March 31, 2027

Conditions
Dermatitis Atopic
Interventions
DRUG

Dupilumab SAR231893 (REGN668)

"Pharmaceutical form: solution for injection~Route of administration: subcutaneous injection"

Trial Locations (114)

100

Investigational Site Number : 1580014, Taipei

333

Investigational Site Number : 1580015, Taoyuan

1090

Investigational Site Number : 0560003, Jette

1200

Investigational Site Number : 0560002, Brussels

1220

Investigational Site Number : 0400001, Vienna

2217

Investigational Site Number : 0360002, Kogarah

Investigational Site Number : 0360005, Kogarah

2344

Investigational Site Number : 0400002, Maria Enzersdorf

2650

Investigational Site Number : 0560007, Edegem

3000

Investigational Site Number : 0560008, Leuven

3053

Investigational Site Number : 0360001, Carlton

4000

Investigational Site Number : 0560001, Leige

4020

Investigational Site Number : 0400004, Linz

4102

Investigational Site Number : 0360003, Woolloongabba

5000

Investigational Site Number : 0560004, Namur

5042

Investigational Site Number : 0360004, Bedford Park

8005

Investigational Site Number : 5780001, Bodø

8036

Investigational Site Number : 0400005, Graz

8800

Investigational Site Number : 0560006, Roeselare

9000

Investigational Site Number : 0560010, Ghent

10126

Investigational Site Number : 3800016, Torino

11001

Investigational Site Number : 1700008, Bogotá

15706

Investigational Site Number : 7240008, Santiago de Compostela

16121

Investigational Site Number : 3000002, Athens

16132

Investigational Site Number : 3800008, Genova

18012

Investigational Site Number : 7240021, Granada

18101

Investigational Site Number : 3760006, Afula

20122

Investigational Site Number : 3800004, Milan

21423

Investigational Site Number : 6820001, Jeddah

25123

Investigational Site Number : 3800007, Brescia

26953

Investigational Site Number : 2500001, Valence

28006

Investigational Site Number : 7240016, Madrid

28031

Investigational Site Number : 7240007, Madrid

28034

Investigational Site Number : 7240006, Madrid

28040

Investigational Site Number : 7240010, Madrid

28041

Investigational Site Number : 7240001, Madrid

28222

Investigational Site Number : 7240012, Majadahonda

31048

Investigational Site Number : 3760005, Haifa

31059

Investigational Site Number : 2500002, Toulouse

31444

Investigational Site Number : 6820013, Dammam

33000

Investigational Site Number : 2500003, Bordeaux

33011

Investigational Site Number : 7240002, Oviedo

33611

Investigational Site Number : 7240011, Santullano de Mieres

34295

Investigational Site Number : 2500009, Montpellier

34761

Investigational Site Number : 7840002, Abu Dhabi

35010

Investigational Site Number : 7240004, Las Palmas de Gran Canaria

40113

Investigational Site Number : 2030001, Ústí nad Labem

40201

Investigational Site Number : 1580011, Taichung

44130

Investigational Site Number : 4840001, Guadalajara

48013

Investigational Site Number : 7240019, Bilbao

48903

Investigational Site Number : 7240017, Barakaldo

50005

Investigational Site Number : 2030008, Hradec Králové

54645

Investigational Site Number : 3000003, Thessaloniki

56126

Investigational Site Number : 3800010, Pisa

56403

Investigational Site Number : 3000001, Thessaloniki

60126

Investigational Site Number : 3800009, Torrette Di Ancona

67100

Investigational Site Number : 3800015, L’Aquila

67200

Investigational Site Number : 2460002, Kokkola

69495

Investigational Site Number : 2500006, Pierre-Bénite

70124

Investigational Site Number : 3800012, Bari

70852

Investigational Site Number : 2030003, Ostrava - Poruba

76000

Investigational Site Number : 2500010, Rouen

76100

Investigational Site Number : 3760003, Rehovot

77900

Investigational Site Number : 2030006, Olomouc

80131

Investigational Site Number : 3800001, Napoli

89000

Investigational Site Number : 2500004, Auxerre

90127

Investigational Site Number : 3800018, Palermo

90806

Investigational Site Number : 4140001, Sulaibikat

91120

Investigational Site Number : 3760002, Jerusalem

92160

Investigational Site Number : 2500011, Antony

94160

Investigational Site Number : 2500005, Saint-Mandé Cedex

110221

Investigational Site Number : 1700012, Bogotá

123182

Investigational Site Number : 6430001, Moscow

129110

Investigational Site Number : 6430002, Moscow

191015

Investigational Site Number : 6430004, Saint Petersburg

833401

Investigational Site Number : 1580012, Kaohsiung City

3109601

Investigational Site Number : 3760001, Haifa

5266202

Investigational Site Number : 3760004, Ramat Gan

B1629ODT

Investigational Site Number : 0320013, Pilar

S2000DBS

Investigational Site Number : 0320012, Rosario

C1121ABE

Investigational Site Number : 0320011, Ciudad Autonoma Bs As

050034

Investigational Site Number : 1700011, Medellín

304 60

Investigational Site Number : 2030004, Pilsen

110 01

Investigational Site Number : 2030005, Prague

150 06

Investigational Site Number : 2030002, Prague

04019

Investigational Site Number : 3800017, Terracina

00133

Investigational Site Number : 3800003, Rome

00161

Investigational Site Number : 3800011, Rome

09124

Investigational Site Number : 3800013, Cagliari

00137

Investigational Site Number : 3800005, Roma

480-1195

Investigational Site Number : 3920004, Nagakute-shi

080-0013

Investigational Site Number : 3920015, Obihiro-shi

060-0807

Investigational Site Number : 3920006, Sapporo

573-1191

Investigational Site Number : 3920011, Hirakata-shi

343-8555

Investigational Site Number : 3920008, Koshigaya-shi

321-0293

Investigational Site Number : 3920005, Shimotsuga-gun

173-8606

Investigational Site Number : 3920003, Itabashi-ku

660-8550

Investigational Site Number : 3920022, Amagasaki-shi

583-8588

Investigational Site Number : 3920002, Habikino-shi

430-0929

Investigational Site Number : 3920014, Hamamatsu

604-8845

Investigational Site Number : 3920025, Kyoto

763-0074

Investigational Site Number : 3920013, Marugame-shi

505-8503

Investigational Site Number : 3920012, Minokamo-shi

454-8509

Investigational Site Number : 3920001, Nagoya

156-0043

Investigational Site Number : 3920010, Setagaya-ku

234-8503

Investigational Site Number : 3920020, Yokohama

4624 VT

Investigational Site Number : 5280002, Bergen op Zoom

N-5021

Investigational Site Number : 5780002, Bergen

3000-075

Investigational Site Number : 6200003, Coimbra

1169-050

Investigational Site Number : 6200002, Lisbon

4099-001

Investigational Site Number : 6200004, Porto

4434-502

Investigational Site Number : 6200001, Vila Nova de Gaia

08041

Investigational Site Number : 7240009, Barcelona

Unknown

Investigational Site Number : 7240014, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Regeneron Pharmaceuticals

INDUSTRY

lead

Sanofi

INDUSTRY